Research Article| Volume 49, ISSUE 3, P221-227, November 15, 2004

Download started.


The effects of hormone therapy on pulmonary function tests in postmenopausal women


      Objective: To investigate the effects of hormone therapy (HT) administered to postmenopausal women on pulmonary function tests (PFT). Methods: Eighty-two postmenopausal women who were having natural or surgically initiated menopause and had no risk factor that could affect the respiratory system were included into this prospective, randomized study. Twenty-five women who refused to use HT were assessed as the control group (Group I). Nineteen women who accepted using HT and who were having surgically initiated menopause were given continuous estrogen (Group II), 23 were given continuous estrogen and progesterone in combination (Group III) and 15 were given cyclic estrogen and progesterone combination (Group IV).
      Forced expiratory volume (FEV1), forced vital capacity (FVC), FEV1/FVC, forced expiratory flow rate over 25–75% of the forced vital capacity volume and peak expiratory flow rate were assessed at the beginning of the treatment and in the third month in order to evaluate the effects of HT regimens on the women’s PFT. Results: A statistically significant increase was observed only in the FEV1 and FVC parameters of Group III after three months of therapy (P<0.05). The comparison between pre- and posttherapy FEV1 and FVC values showed an increase in the Group IV, but the difference was not statistically significant, while there was no difference between basal and third month FEV1 and FVC values of the group receiving estrogen only. Conclusions: It was seen that particularly continuous combined HT regimen positively affected the FEV1 and FVC parameters of the postmenopausal women.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Writing Group for the Women’s Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 2002;288:321–33.

        • Nelson H.D.
        • Humprey L.L.
        • Nygren P.
        • Teutsch S.M.
        • Allan J.D.
        Postmenopausal hormone replacement therapy. Scientific review.
        JAMA. 2002; 288: 872-881
        • Skobeloff E.M.
        • Spivey W.H.
        • Clair St.S.S.
        • Schoffstall J.M.
        The influence of age and sex on asthma admissions.
        JAMA. 1992; 268: 3437-3440
        • Yunginger J.W.
        • Reed C.E.
        • O’Connell E.J.
        • Melton L.J.
        • O’Fallon W.M.
        • Silverstein M.D.
        A community based study of epidemiology of asthma.
        Am. Rev. Respir. Dis. 1992; 146: 888-894
        • Balzano G.
        • Fuschillo S.
        • Melillo G.
        • Bonini S.
        Asthma and sex hormones.
        Allergy. 2001; 56: 13-20
        • Gibbs C.J.
        • Coutts H.
        • Lock R.
        • Finnegan O.C.
        • White R.J.
        Premenstruel exacerbation of asthma.
        Thorax. 1984; 39: 833-836
        • Eliasson O.
        • Scherzer H.H.
        Recurrent respiratory failure in premenstrual asthma.
        Conn. Med. 1984; 48: 777-778
        • Perin B.
        • Bousquet J.
        • Michel F.B.
        • Godard P.
        • Jesuran M.
        • Monabeka H.
        • et al.
        Severe premenstruel asthma.
        Lancet. 1988; 2: 843-844
        • Benyon H.L.C.
        • Garbett N.D.
        • Barnes P.J.
        Severe premenstruel exacerbations of asthma: effect of intramuscular progesterone.
        Lancet. 1988; 2: 370-372
        • Myers J.R.
        • Sherman C.B.
        Should supplemental estrogens be used as steroid-sparing agents in asthmatic women?.
        Chest. 1994; 106: 318-319
        • Chandler M.H.
        • Schuldheisz S.
        • Phillips B.A.
        • Muse K.N.
        Premenstrual asthma: the effect of estrogen on symptoms.
        Pharmacotherapy. 1997; 17: 224-234
        • Seaton A.
        Pulmonary capillary blood volume in women: normal values and the effect of oral contraceptives.
        Thorax. 1972; 27: 75-79
        • Forbes L.
        • Jarvis D.
        • Burney P.
        Do hormonal contraceptives influence asthma severity?.
        Eur. Respir. J. 1999; 14: 1028-1033
        • Lange P.
        • Parner J.
        • Prescott E.
        • Ulrik C.S.
        • Vestbo B.
        Exogenous female sex steroid hormones and risk of asthma-like symptoms: a cross sectional study of the general population.
        Thorax. 2001; 56: 613-616
        • Collins L.C.
        • Peiris A.
        Bronchospasm secondary to replacement estrogen therapy.
        Chest. 1993; 104: 1300-1302
        • Lieberman D.
        • Kopernic G.
        • Porath A.
        • Levitas E.
        • Lazer S.
        • Heimer D.
        Influence of estrogen replacement therapy on airway reactivity.
        Respiration. 1995; 62: 205-208
        • Lieberman D.
        • Kopernic G.
        • Porath A.
        • Lazer S.
        • Heimer D.
        Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women.
        Maturitas. 1995; 21: 153-157
        • Hepburn M.J.
        • Dooley D.P.
        • Morris M.J.
        The effects of estrogen replacement therapy on airway function in postmenopausal, asthmatic women.
        Arch. Intern. Med. 2001; 161: 2717-2720
        • Troisi R.J.
        • Speizer F.E.
        • Willett W.C.
        • Trichopoulos D.
        • Rosner B.
        Menopause, postmenopausal estrogen preparations and the risk of adult-onset asthma.
        Am. J. Respir. Crit. Care Med. 1995; 152: 1183-1188
        • Carlson C.L.
        • Cushman M.
        • Enright P.L.
        • Cauley J.A.
        • Newman A.B.
        Hormone replacement therapy is associated with higher FEV1 in elderly women.
        Am. J. Respir. Crit. Care Med. 2001; 163: 423-428
      2. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995;152:1107–36.

      3. Madama VC. Test for pulmonary mechanics. In: Madama VC, editor. Pulmonary function testing and cardiopulmonary stress testing. 2nd ed. Albany, New York: Delmar Publishers; 1998. p. 30–64.

        • Pata O.
        • Atis S.
        • Oz A.U.
        • Yazici G.
        • Tok E.
        • Pata C.
        • et al.
        The effects of hormone replacement therapy on pulmonary functions in postmenopausal women.
        Maturitas. 2003; 46: 213-218
      4. Ginsburg J, Prelevic GM. The place of tibolone in menopausal therapy. In: Studd J, editor. The management of the menopause. The millenium review 2000. Lancs, UK: Parthenon Publishing Group; 2000. p. 59–68.

        • Kos-Kudla B.
        • Ostrowska Z.
        • Marek B.
        • Ciesielska-Kopacz N.
        • Kajdaniuk D.
        • Kudla M.
        Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women.
        Gynecol. Endocrinol. 2001; 15: 304-311
        • Foster P.S.
        • Goldie R.G.
        • Paterson J.W.
        Effect of steroids on beta-adrenoceptor-mediated relaxation of pig bronchus.
        Br. J. Pharmacol. 1983; 78: 441-445
        • Perusquia M.
        • Hernandez R.
        • Montano L.M.
        • Villalon C.M.
        • Campos M.G.
        Inhibitory effect of sex steroids on guinea-pig airway smooth muscle contractions.
        Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 1997; 118: 5-10
        • Kahlert S.
        • Grohe C.
        • Karas R.H.
        • Lobbert K.
        • Neyses L.
        • Vetter H.
        Effects of estrogen on skeletal myoblast growth.
        Biochem. Biophys. Res. Commun. 1997; 232: 373-378
        • Ben-Harari R.R.
        • Amit T.
        • Youdim M.B.H.
        Binding of oestradiol progesterone and prolactin in rat lung.
        J. Endocrinol. 1983; 97: 301-310
        • Hannart B.
        • Pickett C.K.
        • Moore L.G.
        Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia.
        J. Appl. Physiol. 1990; 68: 1909-1916
        • Popovic M.R.
        • White D.P.
        Upper airway muscle activity in normal women: influence of hormonal status.
        J. Appl. Physiol. 1998; 84: 1055-1062
        • Saaresranta T.
        • Polo-Kantola P.
        • Irjala K.
        • Helenius H.
        • Polo O.
        Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate.
        Chest. 1999; 115: 1581-1587